Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine ...

Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 12.5% in the morning session after Peter Marks, the ...

Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The steep decline comes as the S&P 500 and Nasdaq Composite lost 0.4% ...

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, ...

We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at ...

Key Takeaways The S&P 500 and Nasdaq lost ground at midday as the Trump administration's reciprocal tariffs are set to kick ...

Looking at options history for Moderna (NASDAQ:MRNA) we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020.